<?xml version="1.0" encoding="UTF-8"?>
<p>Previous studies have shown that increase in CpG/UpA dinucleotides is an efficient attenuation mechanism (
 <xref rid="vey021-B3" ref-type="bibr">Atkinson et al. 2014</xref>; 
 <xref rid="vey021-B75" ref-type="bibr">Tulloch et al. 2014</xref>; 
 <xref rid="vey021-B18" ref-type="bibr">Gaunt et al. 2016</xref>; 
 <xref rid="vey021-B78" ref-type="bibr">Witteveldt, Martin-Gans, and Simmonds 2016</xref>) and this was supported by the evidence of a correlation between increased CpG/UpA and attenuation in our hamster models. However, the introduction of TCG trinucleotides affected the 
 <italic>in vivo</italic> phenotype of YFV. 
 <italic>In silico</italic> analysis predicted that such patterns are likely to be selected against in flaviviruses infecting vertebrates. In addition, studies on influenza virus produced evidence that CpG dinucleotides in an A/U context (e.g., TCG) may enhance virus detection by the host innate immune system (
 <xref rid="vey021-B23" ref-type="bibr">Greenbaum et al. 2008</xref>; 
 <xref rid="vey021-B24" ref-type="bibr">Greenbaum, Rabadan, and Levine 2009</xref>; 
 <xref rid="vey021-B32" ref-type="bibr">Jimenez-Baranda et al. 2011</xref>). Such trinucleotides can be used to induce a host-dependent attenuation, as recently demonstrated for dengue virus (
 <xref rid="vey021-B68" ref-type="bibr">Shen et al. 2015</xref>; 
 <xref rid="vey021-B71" ref-type="bibr">Simmonds et al. 2015</xref>).
</p>
